Literature DB >> 32518154

ETS variant transcription factor 5 and c-Myc cooperate in derepressing the human telomerase gene promoter via composite ETS/E-box motifs.

Fan Zhang1, Shuwen Wang1, Jiyue Zhu2.   

Abstract

The human telomerase gene (hTERT) is repressed in most somatic cells. How transcription factors activate the hTERT promoter in its repressive chromatin environment is unknown. Here, we report that the ETS family protein ETS variant transcription factor 5 (ETV5) mediates epidermal growth factor (EGF)-induced hTERT expression in MCF10A cells. This activation required MYC proto-oncogene bHLH transcription factor (c-Myc) and depended on the chromatin state of the hTERT promoter. Using chromatinized bacterial artificial chromosome (BAC) reporters in human fibroblasts, we found that ETV5 and c-Myc/MYC-associated factor X (MAX) synergistically activate the hTERT promoter via two identical, but inverted, composite Ets/E-box motifs enclosing the core promoter. Mutations of Ets or E-box sites in either DNA motif abolished the activation and reduced or eliminated the synergism. ETV5 and c-Myc facilitated each other's binding to the hTERT promoter. ETV5 bound to the hTERT promoter in both telomerase-negative and -positive cells, but it activated the repressed hTERT promoter and altered histone modifications only in telomerase-negative cells. The synergistic ETV5/c-Myc activation disappeared when hTERT promoter repression became relieved because of the loss of distal regulatory elements in chimeric human/mouse BAC reporters. Our results suggest that the binding of c-Myc and ETS family proteins to the Ets/E-box motifs derepresses the hTERT promoter by inducing an active promoter configuration, providing a mechanistic insight into hTERT activation during tumorigenesis.
© 2020 Zhang et al.

Entities:  

Keywords:  ETS transcription factor family; ETS variant transcription factor 5 (ETV5); Ets-related molecule (ERM); MYC proto-oncogene bHLH transcription factor; c-Myc; chromatin; epigenetics; gene regulation; gene transcription; human telomerase gene (hTERT); telomerase; telomerase reverse transcriptase (TERT); telomere; transcription; transcription regulation

Mesh:

Substances:

Year:  2020        PMID: 32518154      PMCID: PMC7380182          DOI: 10.1074/jbc.RA119.012130

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells.

Authors:  D Xu; N Popov; M Hou; Q Wang; M Björkholm; A Gruber; A R Menkel; M Henriksson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Ets-1 binds cooperatively to the palindromic Ets-binding sites in the p53 promoter.

Authors:  David Baillat; Clélia Laitem; Gabriel Leprivier; Charline Margerin; Marc Aumercier
Journal:  Biochem Biophys Res Commun       Date:  2008-11-18       Impact factor: 3.575

3.  The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity.

Authors:  J-L Baert; C Beaudoin; D Monte; C Degerny; S Mauen; Y de Launoit
Journal:  Oncogene       Date:  2006-07-10       Impact factor: 9.867

4.  Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.

Authors:  Kunitoshi Chiba; Franziska K Lorbeer; A Hunter Shain; David T McSwiggen; Eva Schruf; Areum Oh; Jekwan Ryu; Xavier Darzacq; Boris C Bastian; Dirk Hockemeyer
Journal:  Science       Date:  2017-08-17       Impact factor: 47.728

5.  ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer.

Authors:  Martyn Bullock; Grace Lim; Ying Zhu; Helena Åberg; Sergey Kurdyukov; Roderick Clifton-Bligh
Journal:  Thyroid       Date:  2019-10-29       Impact factor: 6.568

6.  ERM is required for transcriptional control of the spermatogonial stem cell niche.

Authors:  Chen Chen; Wenjun Ouyang; Vadim Grigura; Qing Zhou; Kay Carnes; Hyunjung Lim; Guang-Quan Zhao; Silvia Arber; Natasza Kurpios; Theresa L Murphy; Alec M Cheng; John A Hassell; Varadaraj Chandrashekar; Marie-Claude Hofmann; Rex A Hess; Kenneth M Murphy
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

7.  Highly cooperative recruitment of Ets-1 and release of autoinhibition by Pax5.

Authors:  Daniel Fitzsimmons; Kara Lukin; Ryan Lutz; Colin W Garvie; Cynthia Wolberger; James Hagman
Journal:  J Mol Biol       Date:  2009-07-17       Impact factor: 5.469

8.  TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.

Authors:  M Labussière; A L Di Stefano; V Gleize; B Boisselier; M Giry; S Mangesius; A Bruno; R Paterra; Y Marie; A Rahimian; G Finocchiaro; R S Houlston; K Hoang-Xuan; A Idbaih; J-Y Delattre; K Mokhtari; M Sanson
Journal:  Br J Cancer       Date:  2014-10-14       Impact factor: 7.640

9.  Regulation of human and mouse telomerase genes by genomic contexts and transcription factors during embryonic stem cell differentiation.

Authors:  Shuwen Wang; Wenwen Jia; Yuanjun Zhao; Fan Zhang; Jiuhong Kang; Jiyue Zhu
Journal:  Sci Rep       Date:  2017-11-27       Impact factor: 4.379

10.  Studying human telomerase gene transcription by a chromatinized reporter generated by recombinase-mediated targeting of a bacterial artificial chromosome.

Authors:  Shuwen Wang; Yuanjun Zhao; Melanie A Leiby; Jiyue Zhu
Journal:  Nucleic Acids Res       Date:  2009-06-15       Impact factor: 16.971

View more
  1 in total

Review 1.  Molecular Mechanisms of Alveolar Epithelial Stem Cell Senescence and Senescence-Associated Differentiation Disorders in Pulmonary Fibrosis.

Authors:  Xiaojing Hong; Lihui Wang; Kexiong Zhang; Jun Liu; Jun-Ping Liu
Journal:  Cells       Date:  2022-03-03       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.